Degrading the signal amplifier: ITK as a target for targeted protein degradation
- PMID: 37084715
- DOI: 10.1016/j.chembiol.2023.04.001
Degrading the signal amplifier: ITK as a target for targeted protein degradation
Abstract
In this issue of Cell Chemical Biology, Jiang and colleagues show for the first time that the Tec kinase ITK can be targeted using PROTAC approaches. This new modality has implications for the treatment of T cell lymphomas, but also potentially for the treatment of T cell-mediated inflammatory diseases, that depend on ITK signaling.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests A.A. receives research support from 3M Corporation and has received consultation fees from Pfizer.
Comment on
-
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.Cell Chem Biol. 2023 Apr 20;30(4):383-393.e6. doi: 10.1016/j.chembiol.2023.03.007. Epub 2023 Apr 3. Cell Chem Biol. 2023. PMID: 37015223 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
